A.M. Codegoni

629 total citations
23 papers, 509 citations indexed

About

A.M. Codegoni is a scholar working on Molecular Biology, Oncology and Cellular and Molecular Neuroscience. According to data from OpenAlex, A.M. Codegoni has authored 23 papers receiving a total of 509 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 7 papers in Oncology and 5 papers in Cellular and Molecular Neuroscience. Recurrent topics in A.M. Codegoni's work include Cancer-related Molecular Pathways (5 papers), Ovarian cancer diagnosis and treatment (4 papers) and Neuroscience and Neuropharmacology Research (3 papers). A.M. Codegoni is often cited by papers focused on Cancer-related Molecular Pathways (5 papers), Ovarian cancer diagnosis and treatment (4 papers) and Neuroscience and Neuropharmacology Research (3 papers). A.M. Codegoni collaborates with scholars based in Italy, United States and Poland. A.M. Codegoni's co-authors include Massimo Broggini, A. Bizzi, Silvio Garattini, Maurizio D’Incalci, Sara Vignati, Federica Polato, Valter Torri, Tiziana Mennini, Silvio Caccia and Costantino Mangioni and has published in prestigious journals such as Nature, American Journal of Clinical Nutrition and British Journal of Cancer.

In The Last Decade

A.M. Codegoni

23 papers receiving 493 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A.M. Codegoni Italy 14 261 160 91 81 59 23 509
Michael J. McLachlan United States 10 265 1.0× 156 1.0× 36 0.4× 45 0.6× 48 0.8× 13 611
Ya‐Ting Hsu Taiwan 14 255 1.0× 156 1.0× 25 0.3× 106 1.3× 159 2.7× 53 768
Farah Zia United States 19 372 1.4× 242 1.5× 82 0.9× 68 0.8× 372 6.3× 26 866
Rhoda Maneckjee United States 13 630 2.4× 169 1.1× 54 0.6× 68 0.8× 366 6.2× 28 1.0k
Akira Wakizaka Japan 12 222 0.9× 60 0.4× 14 0.2× 64 0.8× 35 0.6× 33 511
Ramon E. Camacho United States 12 208 0.8× 144 0.9× 36 0.4× 51 0.6× 99 1.7× 13 1.1k
M.V. Govindan Canada 15 321 1.2× 83 0.5× 70 0.8× 41 0.5× 61 1.0× 22 804
Natasha C. Lucki United States 13 448 1.7× 62 0.4× 29 0.3× 184 2.3× 20 0.3× 17 696
Katherine A Blood Canada 6 258 1.0× 133 0.8× 145 1.6× 105 1.3× 43 0.7× 6 595
Jerome Schlomer United States 7 122 0.5× 68 0.4× 66 0.7× 51 0.6× 30 0.5× 9 358

Countries citing papers authored by A.M. Codegoni

Since Specialization
Citations

This map shows the geographic impact of A.M. Codegoni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A.M. Codegoni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A.M. Codegoni more than expected).

Fields of papers citing papers by A.M. Codegoni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A.M. Codegoni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A.M. Codegoni. The network helps show where A.M. Codegoni may publish in the future.

Co-authorship network of co-authors of A.M. Codegoni

This figure shows the co-authorship network connecting the top 25 collaborators of A.M. Codegoni. A scholar is included among the top collaborators of A.M. Codegoni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A.M. Codegoni. A.M. Codegoni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Marabese, Mirko, Sergio Marchini, Dario Cattaneo, et al.. (2007). Expression levels of p53 and p73 isoforms in stage I and stage III ovarian cancer. European Journal of Cancer. 44(1). 131–141. 29 indexed citations
2.
Vignati, Sara, A.M. Codegoni, Federica Polato, & Massimo Broggini. (2002). Trail activity in human ovarian cancer cells. European Journal of Cancer. 38(1). 177–183. 56 indexed citations
3.
Erba, Eugenio, Ivan Muradore, Giovanna Chiorino, et al.. (2002). Cell cycle phase perturbations and apoptosis in tumour cells induced by aplidine. British Journal of Cancer. 86(9). 1510–1517. 51 indexed citations
4.
Codegoni, A.M., et al.. (1999). Allelic expression of p73 in human ovarian cancers. Annals of Oncology. 10(8). 949–953. 13 indexed citations
5.
Codegoni, A.M., Francesco Bertoni, Gennaro Colella, et al.. (1999). Microsatellite instability and frameshift mutations in genes involved in cell cycle progression or apoptosis in ovarian cancer.. PubMed. 11(7). 297–301. 20 indexed citations
6.
Bertoni, Francesco, A.M. Codegoni, Daniela Furlan, et al.. (1999). CHK1 frameshift mutations in genetically unstable colorectal and endometrial cancers. European Journal of Cancer. 35. S190–S190. 2 indexed citations
7.
Codegoni, A.M., et al.. (1998). DNA-topoisomerase I activity and content in epithelial ovarian cancer. Annals of Oncology. 9(3). 313–318. 16 indexed citations
8.
Codegoni, A.M., Maria Nicoletti, G.L. Buraggi, et al.. (1998). Molecular characterisation of a panel of human ovarian carcinoma xenografts. European Journal of Cancer. 34(9). 1432–1438. 14 indexed citations
9.
Codegoni, A.M., et al.. (1997). Expression of Genes of Potential Importance in the Response to Chemotherapy and DNA Repair in Patients with Ovarian Cancer. Gynecologic Oncology. 65(1). 130–137. 50 indexed citations
10.
Marchini, Sergio, A.M. Codegoni, Cristina Bonazzi, Stefania Chiari, & Massimo Broggini. (1997). Absence of deletions but frequent loss of expression of p16INK4 in human ovarian tumours. British Journal of Cancer. 76(2). 146–149. 35 indexed citations
11.
Conforti, G, A.M. Codegoni, Eugenio Scanziani, et al.. (1995). Different vimentin expression in two clones derived from a human colocarcinoma cell line (LoVo) showing different sensitivity to doxorubicin. British Journal of Cancer. 71(3). 505–511. 16 indexed citations
12.
Cantoni, L, M. Rizzardini, Alfredo Cagnotto, et al.. (1992). Hepatic protoporphyria is associated with a decrease in ligand binding for the mitochondrial benzodiazepine receptors in the liver. Biochemical Pharmacology. 44(6). 1159–1164. 13 indexed citations
13.
Garattini, Silvio, A. Bizzi, A.M. Codegoni, Silvio Caccia, & Tiziana Mennini. (1992). Progress report on the anorexia induced by drugs believed to mimic some of the effects of serotonin on the central nervous system. American Journal of Clinical Nutrition. 55(1). 160S–166S. 28 indexed citations
14.
Bizzi, A., et al.. (1992). Anorectic activity of fluoxetine and norfluoxetine in mice, rats and guinea-pigs. Journal of Pharmacy and Pharmacology. 44(8). 696–698. 30 indexed citations
15.
Ferrarese, Carlo, Tiziana Mennini, N. Pecora, et al.. (1991). Diazepam binding inhibitor (DBI) increases after acute stress in rat. Neuropharmacology. 30(12). 1445–1452. 48 indexed citations
16.
Mingardi, G., Francesco Branca, Michela Cini, et al.. (1988). Factors Affecting Plasma Free Fatty Acids Rise during Hemodialysis. The International Journal of Artificial Organs. 11(2). 95–98. 2 indexed citations
17.
Bizzi, A., M.T. Tacconi, A.M. Codegoni, et al.. (1980). Accumulation and metabolism of uneven fatty acids present in single cell protein. Toxicology Letters. 5(3-4). 227–240. 7 indexed citations
18.
Bizzi, A., A.M. Codegoni, & Silvio Garattini. (1969). The hypersensitivity of adipose tissue to norepinephrine and other lipolytic agents during blockade of free fatty acids (FFA) mobilization. Biochemical Pharmacology. 18(9). 2053–2060. 3 indexed citations
19.
Bizzi, A., et al.. (1968). Different responses of white and brown adipose tissue to drugs affecting lipolysis. Biochemical Pharmacology. 17(12). 2407–2412. 5 indexed citations
20.
Bizzi, A., A.M. Codegoni, & Silvio Garattini. (1964). Salicylate, a Powerful Inhibitor of Free Fatty Acid Release. Nature. 204(4964). 1205–1205. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael J. McLachlan Breakdown of academic impact, for papers by Ya‐Ting Hsu Breakdown of academic impact, for papers by Farah Zia Breakdown of academic impact, for papers by Rhoda Maneckjee Breakdown of academic impact, for papers by Akira Wakizaka Breakdown of academic impact, for papers by Ramon E. Camacho Breakdown of academic impact, for papers by M.V. Govindan Breakdown of academic impact, for papers by Natasha C. Lucki Breakdown of academic impact, for papers by Katherine A Blood Breakdown of academic impact, for papers by Jerome Schlomer
Rankless by CCL
2026